Risk management of QTc-prolongation in patients receiving haloperidol: an epidemiological study in a University hospital in Belgium
Crossref DOI link: https://doi.org/10.1007/s11096-015-0242-9
Published Online: 2016-01-09
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Vandael, Eline
Vandenberk, Bert
Vandenberghe, Joris
Spriet, Isabel
Willems, Rik
Foulon, Veerle
Funding for this research was provided by:
Agentschap voor Innovatie door Wetenschap en Technologie (BE)
Fonds Wetenschappelijk Onderzoek (BE)
Text and Data Mining valid from 2016-01-09